Speaker: Abdul Khalfan CQE, SSGB
Principal, Quality Assurance & Reliability Engineering Consulting Services
Speaker: Abdul Khalfan CQE, SSGB
Principal, Quality Assurance & Reliability Engineering Consulting Services
You are invited to the Graham Seed Fund Launch Event on Monday, October 31 at 12:00 p.m. ET, presented by Transformative Health Technologies.
Dr. Forster will describe the motivations for change in healthcare and describe how the Ottawa Hospital is supporting transformation using three related concepts: learning systems, data democratization, and open innovation. At the foundation of these concepts is a need for strong leadership and trust to support the meaningful collaborations required to achieve meaningful impacts.
The Web-Accessible Population Pharmacokinetic Service – Hemophilia (WAPPS-Hemo) is a clinical decision support tool aimed at using pharmacokinetics of prophylactic clotting factor replacement therapy as a means for individu
The basic principles and experimental set-ups for Edge Illumination and Beam Tracking X-ray phase-contrast imaging (XPCI) are introduced, along with examples on key applications where phase-based imaging complements and advances the more conventional attenuation-based X-ray imaging. X-ray dark-field techniques are also discussed with an emphasis on the most recent developments on tomography and directional imaging.
The Centre for Bioengineering and Biotechnology (CBB) is proud to announce that registration for the forthcoming conference “Waterloo for Health, Technology and Society
The Centre for Bioengineering and Biotechnology (CBB) is proud to announce that registration for the forthcoming conference “Waterloo for Health, Technology and Society
Profs Present: Wearable sensors to inform mobility and health: Novel applications and advances in methodology
DNA aptamers are single-stranded DNA oligonucleotides that can selectively bind to target molecules. They can be used for the detection of various metabolites and proteins as disease biomarkers. Our lab recently discovered new aptamers that can bind to caffeine, uric acid and lactate, and converted them to highly sensitive and selective fluorescent biosensors. In addition, we have isolated aptamers that can bind to exosomes, which could be used for the isolation and detection of exosomes as important disease biomarkers. Finally, we have isolated aptamers that can bind to pig cornea and established an aptamer-enhanced ocular drug delivery method to treat dry eye diseases.